Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 291 · FY2023 2,264 · FY2024 375 — 3-yr total 2,930
Pharmacy chain/pharmaceuticals distributor operating in Georgia.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 2,383 | 5,925 | 8,291 | 10,517 | 14,452 | 12,657 | 14,872 | +35.7% | |
| 2,885 | 136 | 234 | 300 | 685 | 775 | 1,691 | -8.5% | |
| TOTAL ASSETS | 5,267 | 6,061 | 8,525 | 10,817 | 15,137 | 13,432 | 16,563 | +21.0% |
| 3,447 | 3,314 | 3,599 | 3,568 | 4,088 | 1,880 | 3,483 | +0.2% | |
| Total Non-Current Liabilities | 0 | 242 | 0 | 0 | 0 | 0 | 0 | nmf |
| TOTAL LIABILITIES | 3,447 | 3,556 | 3,599 | 3,568 | 4,088 | 1,880 | 3,483 | +0.2% |
| Total Equity | 1,820 | 2,505 | 4,926 | 7,249 | 11,050 | 11,552 | 13,080 | +38.9% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 956 | 1,372 | 242 | 0 | 0 | 0 | 0 | -49.7% |
| Cash & Equivalents | 294 | 328 | 652 | 1,962 | 3,374 | 1,410 | 1,279 | +27.8% |
| Net Debt | 662 | 1,044 | 410 | 1,962 | 3,374 | 1,410 | 1,279 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →